KALI (BPC-157 | MOTS-c | Tesamorelin | 5-Amino-1MQ) A metabolic support peptide blend designed to complement GLP-1 therapies by preserving lean muscle and maintaining energy levels
We believe in a holistic and patient-centered approach, ensuring that all aspects of your health are considered when making treatment decisions
Contact us to schedule an appointment
Based on preclinical studies, a systematic review of the neuroprotective mechanisms of GLP-1RA-based therapy in ischemic stroke [67] has shown that administration of drugs of this family before, during, or after an experimental stroke in animals with and without diabetes modulates an acute inflammatory response secondary to brain ischemia, reducing inflammation, endothelial dysfunction and excitotoxicity, as well as decreasing oxidative stress and apoptosis
"RD-Developed" indicates a registered dietitian (RD/RDN) is credited in meal development
TRT also helps reduce the amount of atherosclerotic plaquefatty, cholesterol-rich deposits that collect inside artery walls and narrow blood flowwhich could offer protection to people with cardiovascular disease